1-2 of 2
Marissa K. Falkiewicz
Close
Sort by
Journal Articles

Benefit of Consolidative Autologous Stem Cell Transplantation in First Complete Remission for Patients with Double Hit Lymphoma Appears Dependent on Induction Regimen Intensity

Daniel J. Landsburg, MD, Nishitha Reddy, MD MSCI, MBBS, Christina Howlett, PharmD, BCOP, Tatyana Feldman, MD, Anthony R. Mato, MD MSCE, Jason B Kaplan, MD, Amir Behdad, MD, Adam M. Petrich, MD, Joseph Maly, MD, Kristie Blum, MD, Julio C. Chavez, MD, Shaoying Li, MD, L. Jeffrey Medeiros, MD, Marissa K. Falkiewicz, Brian T. Hill, MD PhD, Arun Singavi, MD, Timothy S. Fenske, MD, James Gerson, MD, Stefan Klaus Barta, MD MRCP, MS, Pallawi Torka, MD, Francisco J. Hernandez-Ilizaliturri, MD, Cristiana A Costa, DO, Frederick Lansigan, MD, Oscar Calzada, BS, Jonathon B. Cohen, MD, Jennifer Kimberly Lue, MD, Jennifer E Amengual, MD, Xavier Rivera, Daniel Oscar Persky, MD, David Peace, MD, Ryan D Cassaday, MD
Journal: Blood
Blood (2016) 128 (22): 3455.
https://doi.org/10.1182/blood.V128.22.3455.3455
Published: 2016
Journal Articles

Patients with "Single-Hit" but Not MYC -Amplified Non-Burkitt High-Grade B Cell Non-Hodgkin Lymphomas Experience Poor Survival Outcomes and May Benefit from Intensive Induction Therapy

Daniel J. Landsburg, MD, Marissa K. Falkiewicz, Jennifer J.D. Morrissette, PhD, April M. Schrank-Hacker, Sunita Dwivedy Nasta, MD, Jakub Svoboda, MD, Stephen J. Schuster, MD, Anthony R. Mato, MD, Benjamin A. Chu, Yanming Zhang, MD, Amir Behdad, MD, Adam M. Petrich, MD
Journal: Blood
Blood (2015) 126 (23): 2696.
https://doi.org/10.1182/blood.V126.23.2696.2696
Published: 2015